RxDoctor Payments Data

Mendy Shepard

Psychiatric/Mental Health · Ottumwa, IANPI 1205588191

Payments from drug & device makers

$1,969in general payments, 2019–2025

Across 118 payments — averaging $16.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$680
  • Teva Pharmaceuticals USA, Inc.$322
  • Otsuka America Pharmaceutical, Inc.$276
  • Vanda Pharmaceuticals Inc.$150
  • Neurocrine Biosciences, Inc.$126
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$103
  • plus $310 from 9 others

What the payments were for

  • Food & beverage$1,85994%
  • Education$1096%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,969 in reported general payments places this provider in the 70th percentile of 443 psychiatric/mental health providers in Iowa.

See all psychiatric/mental health providers in Iowa

Medicare billing

Part B allowed, 2024
$17,788
Medicare patients
55
Services billed
232

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AristadaAripiprazole Lauroxil35$133,990
VraylarCariprazine Hcl76$88,177
RexultiBrexpiprazole18$30,594
TrintellixVortioxetine Hydrobromide17$11,778
Quetiapine Fumarate296$8,417
Chlorpromazine Hcl35$6,419
Aripiprazole101$4,289
Olanzapine126$3,899
Divalproex Sodium102$2,579
Memantine Hcl ErMemantine Hcl24$1,734
Lurasidone Hcl32$1,594
Mirtazapine132$1,261
Divalproex Sodium ErDivalproex Sodium63$1,217
Risperidone90$1,065
Trazodone Hcl150$940

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Alkermes, Inc.Aristada$28$133,99035 claims
AbbVieVraylar$680$88,17776 claims
Otsuka America Pharmaceutical, Inc.Rexulti$276$30,59418 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$48$11,77817 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 443 psychiatric/mental health providers in Iowa.

Other psychiatric/mental health in Ottumwa

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →